Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions

被引:22
作者
Barrett, PHR
Watts, GF
机构
[1] Univ Western Australia, Dept Med, Lipoprot Res Unit, Perth, WA 6847, Australia
[2] Western Australian Inst Med Res, Perth, WA, Australia
关键词
lipoproteins; apolipoproteins; dyslipoproteinemia; tracers; kinetics; metabolism;
D O I
10.1097/01.mol.0000052851.26236.75
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nutritional interventions may favourably regulate dyslipoproteinemia and, hence, decrease cardiovascular disease risk. Lipoprotein kinetic studies afford a powerful approach to understanding and defining the mechanisms by which such interventions modulate lipoprotein metabolism. Stable isotope tracers and compartment models are now commonly employed for such studies. We review the recent application of tracer methodologies to the study of dyslipoproteinemia in the metabolic syndrome. We also focus on the effects of nutritional intervention studies that have addressed the effects of weight loss, n-3 fatty acids, plant sterols and alcohol on very low density lipoprotein, LDL and HDL metabolism. The potential for statin treatment as an adjunct to dietary modification is also discussed. New tracer methodologies are discussed, specifically those referring to reverse cholesterol transport. The nutritional interventions discussed in this review are readily transferable into clinical preventive practice. The potential benefits to be gained by weight loss and fish oil supplementation in the metabolic syndrome extend beyond their specific and positive effects on lipoprotein metabolism. Furthermore, recent developments in tracer methodologies afford new tools for probing the in-vivo pathways of lipoprotein metabolism in future studies.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 71 条
[11]   Apolipoprotein B-100 kinetics in visceral obesity: Associations with plasma apolipoprotein C-III concentration [J].
Chan, DC ;
Watts, GF ;
Redgrave, TG ;
Mori, TA ;
Barrett, PHR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (08) :1041-1046
[12]   Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity [J].
Chan, DC ;
Watts, GF ;
Mori, TA ;
Barrett, PHR ;
Beilin, LJ ;
Redgrave, TG .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (06) :429-436
[13]   Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity [J].
Chan, DC ;
Watts, GF ;
Barrett, PHR ;
Mori, TA ;
Beilin, LJ ;
Redgrave, TG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) :2283-2289
[14]  
Chan DC, 2002, CLIN CHEM, V48, P278
[15]   Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia [J].
Chan, DC ;
Watts, GF ;
Barrett, PHR ;
Beilin, LJ ;
Redgrave, TG ;
Mori, TA .
DIABETES, 2002, 51 (08) :2377-2386
[16]  
CHAN DC, IN PRESS AM J CLIN N
[17]   The differential apoA-I enrichment of preβ1 and αHDL is detectable by gel filtration separation [J].
Chétiveaux, M ;
Nazih, H ;
Ferchaud-Roucher, V ;
Lambert, G ;
Zaïr, Y ;
Masson, M ;
Ouguerram, K ;
Bouhours, D ;
Krempf, M .
JOURNAL OF LIPID RESEARCH, 2002, 43 (11) :1986-1993
[18]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[19]  
Dashti N, 1996, J LIPID RES, V37, P810
[20]   Inefficiency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus [J].
Duvillard, L ;
Pont, F ;
Florentin, E ;
Gambert, P ;
Vergès, B .
ATHEROSCLEROSIS, 2000, 152 (01) :229-237